Case reports published in the Journal of Cardiovascular and Interventional Radiology have found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels. This is seen as a significant advance that may enable physicians to safely extend liver cancer treatment to patients who were previously deemed untreatable.
The American College of Cardiology (ACC) announced the publication of detailed criteria to help clinicians optimize the appropriate use of certain noninvasive vascular tests when caring for patients with known or suspected disorders of the venous system. Also included are first-time recommendations for when and how to use these tests to plan for or evaluate dialysis access placement. The authors stress that these criteria should not supersede sound clinical judgment for individual patients.
Teleflex Incorporated (Limerick, PA) announced the launch of the Arrow JACC (jugular axillo-subclavian central catheter), which features the company’s Chloragard technology. The device is a small-French size antimicrobial and antithrombogenic catheter that is designed for both acute and long-term use. The Arrow JACC’s Chloragard technology fights thrombosis and infection for up to 30 days and is effective against the full spectrum of bacterial and fungal pathogens. The Arrow JACC received US Food and Drug Administration clearance in November 2012.
In the Journal of the American College of Cardiology (JACC), Mark I. Davis, MD, et al published a systematic review and meta-analysis of sympathetic renal denervation (RDN) to determine the therapy’s current safety and effectiveness as a treatment for resistant hypertension (2013;62:231–241). The investigators noted that RDN is a novel approach that thus far has been evaluated in multiple small studies.
Sirtex Medical and US-based Surefire Medical has announced a sales and marketing partnership to distribute Surefire’s range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets.
An abstract presentation during EuroPCR 2013 (21–24 May, Paris, France) focused on assessing the number and quality of published clinical trials underpinning the wide use of renal denervation in Germany. It strongly made the point that in the past, clinical trial data on the procedure had been scarce and that the long-term durability of treatment effects had not been proven in a large number of patients.
A study, published online on 8 July in the Journal of Vascular and Interventional Radiology, found that peripheral interventional radiologists who use CT perfusion imaging for patient selection had good neurologic outcomes when they treated stroke patients.
Celsion Corporation announced that Ronnie TP Poon, professor of Surgery at the University of Hong Kong and lead Asia Pacific principal investigator for the company’s phase III HEAT study of ThermoDox in hepatocellular carcinoma will present the official clinical trial results from the HEAT study at the International Liver Cancer Association (ILCA) 7th annual conference (September 13–15 Washington DC, USA).
Quienes dedican mucho tiempo a la lectura, la escritura u otras formas de procesar nueva información perderían la memoria y otras habilidades cognitivas más lentamente con la edad. Un equipo halló que mantenerse "cognitivamente activo" en la juventud y la madurez está asociado con un mejor rendimiento en las pruebas de memoria a los 80 años.
Case reports published in the Journal of Cardiovascular and Interventional Radiology have found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels. This is seen as a significant advance that may enable physicians to safely extend liver cancer treatment to patients who were previously deemed untreatable.
Published online in the Journal of Hepatology the results of a new analysis by members of the multi-centre European Network on Radioembolisation with Yttrium-90 Resin Microspheres (ENRY), has showed published possible important implications for older patients with inoperable primary liver cancer (hepatocellular carcinoma).
Unos científicos japoneses informan de que han convertido un grupo mezclado de células madre en los primeros hígados funcionales del mundo. Los hígados de pequeñas dimensiones fueron creados en el laboratorio y trasplantados en ratones, en los que crecieron y empezaron a realizar las mismas funciones que los hígados del tamaño de los humanos, incluyendo el metabolismo de los fármacos y la generación de las proteínas específicas de los hígados.
Launched by the Assistance Publique Hôpitaux de Paris, France, in December 2011, SARAH (Sorafenib versus radioembolization in advanced hepatocellular carcinoma), a French national collaborative randomised controlled trial of radioembolization with yttrium-90 resin microspheres vs. sorafenib in advanced hepatocellular carcinoma has announced it is seeking to enrol 400 patients. To date, according to a press release, more than 150 patients have taken part in this study.
Investigadores hallaron que la frecuencia de los procedimientos cardíacos comunes no urgentes en 12 estados de Estados Unidos varía ampliamente, sin importar si los médicos cobraban por cantidad o por procedimiento. "Debe ser bastante desconcertante tener cuatro veces más probabilidad de ser sometido a un procedimiento sólo por ir a uno u otro hospital del país", dijo el autor principal del estudio, doctor Daniel Matlock, de la Facultad de Medicina de University of Colorado, Denver.
El uso de las inyecciones epidurales de esteroides (ESI, por su nombre en inglés) está asociado con un mayor riesgo de padecer sangrado vaginal anormal, según un estudio de California. "Hay muy pocos datos sobre la relación entre el uso de esteroides epidurales y el riesgo de hemorragia", dijo por correo electrónico el doctor James L. Mura. Y estos resultados "evitarían que algunas mujeres reciban un tratamiento innecesario".
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos